Evelina Zimovetz, MSc

Director, Market Access and Outcomes Strategy
Evelina Zimovetz
Practice Area:
Therapeutic Expertise:
Manchester, United Kingdom

MSc, Operational Research and Applied Statistics
University of Salford, Salford, United Kingdom

BSc, Management Science with Economics
University of Northampton, Northampton, United Kingdom

Evelina Zimovetz, MSc, is a Director in the Market Access and Outcomes Strategy group at RTI HS. She has more than 14 years of experience conducting health economics and outcomes research. Ms. Zimovetz has developed cost-effectiveness, cost-utility, and budget-impact models, pricing and reimbursement strategies, global value dossiers, and objection handling materials and contributed to the development of mixed-treatment comparison meta-analyses. She has extensive experience in conducting both clinical and economic systematic reviews to HTA standards. Ms. Zimovetz has led health technology assessment submissions for NICE and SMC, incorporating economic modelling, systematic reviews, and meta-analyses. She has also led numerous expert advisory boards, blending her technical skills in health economics with her experience conducting market access projects. Her expertise includes the therapeutic areas of attention-deficit/hyperactivity disorder; depression/anxiety; multiple sclerosis; ulcerative colitis and Crohn’s disease; diabetes; oncology (melanoma, soft tissue carcinoma, breast, and non-small cell lung cancer); rheumatoid arthritis; osteoporosis; neuropathic pain; allergic rhinitis; and rare diseases (acromegaly, paroxysmal nocturnal hemoglobinuria, and haemophilia).

Ms. Zimovetz’s work has led to articles in publications such as European Journal of Health Economics, Current Medical Research and Opinion, and CNS Drugs, as well as presentations at conferences such as the International Society for Pharmacoeconomics and Outcomes (ISPOR) and the European Congress of Psychiatry (EPA).